Skip to main content
ONO PHARMACEUTICAL CO., LTD. logo

ONO PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 4528 ISIN · JP3197600004 LEI · 529900G26L4NG4GFJZ86 T Manufacturing
Open in API
Filings indexed 65 across all filing types
Latest filing 2022-11-04 Interim / Quarterly Rep…
Country JP Japan
Listing T 4528

About ONO PHARMACEUTICAL CO., LTD.

https://www.ono-pharma.com/en

Ono Pharmaceutical Co., Ltd. is a research and development-oriented pharmaceutical company dedicated to discovering and developing innovative medicines. With a history spanning over 300 years since its founding in 1717, the company focuses on addressing unmet medical needs for patients worldwide. Its primary research and development areas are oncology, immunology, and neurology. Ono Pharmaceutical is committed to creating unique, first-in-class drugs and is particularly recognized for its pioneering work in the field of immuno-oncology. The company's portfolio consists of prescription pharmaceuticals aimed at treating a range of diseases and conditions.

Recent filings

Filing Released Lang Actions
四半期報告書－第75期第2四半期(令和4年7月1日－令和4年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Ono Pharmaceutical Co., Ltd. with the Kanto Local Finance Bureau on November 4, 2022. It covers the second quarter of the 75th fiscal year (July 1, 2022, to September 30, 2022). It contains detailed financial statements, management analysis, and business information, which aligns with the definition of an Interim/Quarterly Report (IR). Q2 2023
2022-11-04 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It specifically confirms the accuracy of the contents of the Quarterly Report (Shihanki Hokokusho) for the second quarter of the 75th fiscal period. Since this is a regulatory filing confirming the validity of a report rather than the report itself, and it does not fit into specific categories like 10-K or IR, it falls under the general regulatory filing category.
2022-11-04 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act of Japan. It specifically confirms the accuracy of the contents of a Quarterly Report (Shihanki Hokokusho) for the first quarter of the 75th fiscal period. Since this is a regulatory filing confirming the validity of a report rather than the quarterly report itself, and it does not fit into other specific categories like 'RPA' (which is for announcements of report availability), it falls under the general regulatory filing category.
2022-08-05 Japanese
四半期報告書－第75期第1四半期(令和4年4月1日－令和4年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, management analysis (MDA), and operational updates for the first quarter of the 75th fiscal period (April 1, 2022, to June 30, 2022). As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. Q1 2023
2022-08-05 Japanese
内部統制報告書－第74期(令和3年4月1日－令和4年3月31日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act in Japan. It details the framework, scope, and results of the company's internal controls over financial reporting. Since it is a standalone regulatory filing regarding internal control systems and does not fit into the other specific categories like 10-K or IR, it is classified as a Regulatory Filing (RNS).
2022-06-24 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act of Japan. It is a mandatory filing that accompanies the Annual Securities Report (Yukashoken Hokokusho) to confirm the accuracy of the report's contents. Since it is a regulatory filing required by law to accompany the annual report but is not the annual report itself, and does not fit into other specific categories like 'RPA' or '10-K', it is classified as a Regulatory Filing (RNS). FY 2022
2022-06-24 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.